Heart attack prevention showdown: proactive care vs. standard care
NCT ID NCT03439267
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a proactive approach to preventing heart disease, with or without using a coronary calcium scan, works better than standard care. About 5,765 adults at moderate risk for heart problems but with no known heart disease are taking part. The goal is to see if this strategy reduces major events like heart attacks, strokes, or death.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
5,765 people
The number who actually took part.
- Started
-
Mar 2018
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Male subjects 50 to 80 years of age or female subjects 60 to 80 years of age, of any ethnic origin 2. Ability to understand and provide agreement to study participation, which must be obtained prior to initiation of any study procedures 3. No known history, as documented in the EHR, of coronary artery disease, cerebrovascular disease, peripheral vascular disease, or diabetes mellitus at enrollment 4. Willing and able to provide access to their EHR until study end 5. Willing and able to undergo a computed tomography (CT) coronary artery calcium screening test 6. Current and/or past patients seen at Intermountain facilities and who have accessible EHR at the facility(ties) where they are seen. Exclusion Criteria: 1. Patients who have active on-going cancer or are on dialysis 2. Any evidence of statin use prior to study participation 3. Participation in any other clinical trials involving investigational or marketed products within 30 days prior to entry in the study 4. Any evidence of a CAC test within the last 5 years prior to screening 5. The Study Doctor(s) determine(s) that the subject is not eligible for participation in this research study 6. The subject is non-English speaking, and therefore may be unable to fully understand the written and spoken instructions that may relate to the proper conduct of the trial
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiovascular primary prevention strategy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Intermountain Medical Center and Intermountain Clinics
Murray, Utah, 84143, United States